Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis.
Sign Up to like & getrecommendations! Published in 2017 at "Clinical science"
DOI: 10.1042/cs20160438
Abstract: Studies suggest that metformin, widely used for treating Type 2 diabetes, possesses innate antineoplastic properties. For metabolic syndrome patients with hepatocellular carcinoma (HCC), metformin may provide antitumoral effects. We evaluated the impact of metformin on tumour… read more here.
Keywords: strong antineoplastic; preclinical models; mice; hfd mice ... See more keywords